Breaking News Instant updates and real-time market news.

CGC

Canopy Growth

$41.75

1.035 (2.54%)

06:38
04/17/19
04/17
06:38
04/17/19
06:38

Canopy Growth initiated with a Buy at BofA/Merrill

BofA/Merrill analyst Christopher Carey initiated Canopy Growth (CGC) with a Buy and $70 price target saying it is positioned to be a long-term leader in the global cannabis sector. Carey said Canopy has scale with 6M square feet of cultivation capacity, capital following the Constellation (STZ) $4B investment, and vision as it lays groundwork to excel in areas higher on the value chain.

CGC Canopy Growth
$41.75

1.035 (2.54%)

04/04/19
JEFF
04/04/19
NO CHANGE
Target $255
JEFF
Buy
Jefferies views Constellation sale of wine brands favorably
Earnings dilution from a sale of wine brands, along with Canopy Growth (CGC) investment dilution in fiscal 2020 has been an overhang for Constellation Brands (STZ) in recent months, Jefferies analyst Kevin Grundy tells investors in a research note. The analyst says that despite negative earnings implications, he views Constellation's sale of value wine brands to E. & J. Gallo for $1.7B favorably as the "consideration appears reasonable for a declining wine business." Further, and importantly, the sale shifts focus to the company's higher "growth/margin/return" portfolio of assets, namely beer, contends Grundy. Constellation remains the analyst's top pick with a Buy rating and $255 price target.
04/05/19
MSCO
04/05/19
NO CHANGE
Target $230
MSCO
Overweight
Constellation Brands' FY20 guidance looks conservative, says Morgan Stanley
Morgan Stanley analyst Dara Mohsenian said he was surprised by the magnitude of the "relief rally" in Constellation Brands (STZ) shares following the company's Q4 report given that the company reported greater than expected near-term EPS dilution from its low-end wine sale, realized a lower than expected multiple on the wine transaction and unexpectedly did not provide forward guidance for Canopy Growth (CGC) equity losses. With that said, he sees "two clear positives" emerging from the quarter: the fact that fundamentals in the beer business remain solid and the fact that he sees solid visibility that Constellation can hit the high end of if $8.50-$8.80 FY20 EPS guidance, leaving aside Canopy equity losses. The analyst lowered his FY20 and FY21 EPS estimates to reflect dilution from the wine asset sale and trimmed his price target to $230 from $233, but he keeps an Overweight rating on Constellation shares.
04/08/19
COWN
04/08/19
NO CHANGE
COWN
Cowen moderates near-term expectations for cannabis group on supply constraints
After hosting investor meetings with the management of Tilray (TLRY), Cowen analyst Vivien Azer said that Canada clearly remains supply constrained and that Tilray, with its asset-light approach, is overexposed to this supply tightness. Independent of commentary from the meetings with Tilray, Azer lowered her revenue estimates throughout her Canadian cannabis coverage as her current read suggests that Q1 growth will likely be modest. Despite her moderation of her near-term expectations, Azer keeps Outperform ratings on Aurora Cannabis (ACB), Canopy Growth (CGC) and Tilray (TLRY) and maintains a Market Perform rating on Cronos (CRON).
04/12/19
PIPR
04/12/19
NO CHANGE
Target $60
PIPR
Overweight
Canopy Growth Q4 revenue estimate lowered at Piper Jaffray
Piper Jaffray analyst Michael Lavery trimmed his Q4 revenue estimates for Canopy Growth to reflect a more conservative build, based on early quarter Health Canada data. Based on April channel checks, product supply to retailers has recently improved, and stores are now maintaining some product inventory, Lavery tells investors in a research note However, Health Canada January industry data show industry momentum ramping up a bit more slowly than expected, adds the analyst. As such, Lavery lowered his Q4 revenue estimate for Canopy Growth to C$96.8M from C$117.6M. Capacity, scale and execution will continue to matter for the next 12-24 months, as growing supply catches up with strong demand in both Europe and Canada, says the analyst. He considers Canopy well positioned relative to its peers on these measures. Lavery keeps an Overweight rating on Canopy Growth shares with a $60 price target.

TODAY'S FREE FLY STORIES

CE

Celanese

$104.50

-0.7 (-0.67%)

16:46
04/22/19
04/22
16:46
04/22/19
16:46
Earnings
Celanese reports Q1 adjusted EPS $2.62, consensus $2.41 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

SIMO

Silicon Motion

$42.15

-0.52 (-1.22%)

16:44
04/22/19
04/22
16:44
04/22/19
16:44
Downgrade
Silicon Motion rating change  »

Silicon Motion cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 28

    May

TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:42
04/22/19
04/22
16:42
04/22/19
16:42
Hot Stocks
Tesla CEO sees Robotaxis on the road in 2020 »

Says cost of Robotaxi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

16:39
04/22/19
04/22
16:39
04/22/19
16:39
Conference/Events
SunTrust gov't affairs analysts to hold an analyst/industry conference call »

Analysts hold an…

BA

Boeing

$375.02

-5 (-1.32%)

, TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:38
04/22/19
04/22
16:38
04/22/19
16:38
On The Fly
Fly Intel: Wall Street's top stories for Monday »

The major averages were…

BA

Boeing

$375.02

-5 (-1.32%)

TSLA

Tesla

$262.90

-10.35 (-3.79%)

KMB

Kimberly-Clark

$130.24

6.76 (5.47%)

GWW

Grainger

$291.05

-17.215 (-5.58%)

SSNLF

Samsung

$0.00

(0.00%)

KEYW

KEYW

$11.16

3.31 (42.17%)

JEC

Jacobs Engineering

$78.69

1.755 (2.28%)

AKRX

Akorn

$2.98

0.21 (7.58%)

EAF

GrafTech

$12.35

-1.58 (-11.34%)

ISRG

Intuitive Surgical

$490.70

-37.34 (-7.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 29

    Apr

  • 29

    Apr

  • 01

    May

  • 01

    May

  • 01

    May

  • 02

    May

  • 03

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 09

    May

  • 20

    May

  • 29

    May

  • 05

    Jun

TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:38
04/22/19
04/22
16:38
04/22/19
16:38
Hot Stocks
Tesla CEO sees Model S/3/X production of 10,000/wk in 2019 »

Sees reaching Model S,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

LENS

Presbia

$0.56

-0.0034 (-0.61%)

16:38
04/22/19
04/22
16:38
04/22/19
16:38
Hot Stocks
Breaking Hot Stocks news story on Presbia »

Presbia trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$12.77

0.1 (0.79%)

16:36
04/22/19
04/22
16:36
04/22/19
16:36
Hot Stocks
Alder Biopharmaceuticals: FDA accepts for review the BLA for eptinezumab »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

GPC

Genuine Parts

$103.62

-1.84 (-1.74%)

16:33
04/22/19
04/22
16:33
04/22/19
16:33
Hot Stocks
Genuine Parts CEO Paul Donahue to also serve as board chairman »

Genuine Parts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

TSLA

Tesla

$262.90

-10.35 (-3.79%)

16:32
04/22/19
04/22
16:32
04/22/19
16:32
Hot Stocks
Tesla says Autopilot observes driver, pedestrian tendencies »

Says Autopilot uses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 24

    Apr

HSTM

HealthStream

$27.23

0.11 (0.41%)

16:32
04/22/19
04/22
16:32
04/22/19
16:32
Earnings
HealthStream backs FY19 revenue view $251M-$258M, consensus $255.84M »

Raises FY19 CapEx view to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 28

    May

HSTM

HealthStream

$27.23

0.11 (0.41%)

16:31
04/22/19
04/22
16:31
04/22/19
16:31
Earnings
HealthStream reports Q1 EPS 15c, consensus 7c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 28

    May

RCKT

Rocket Pharmaceuticals

$17.78

0.91 (5.39%)

16:31
04/22/19
04/22
16:31
04/22/19
16:31
Initiation
Rocket Pharmaceuticals initiated  »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GES

Guess

$16.66

-0.41 (-2.40%)

16:30
04/22/19
04/22
16:30
04/22/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Guess »

Guess down 3.9% at $16…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
04/22/19
04/22
16:30
04/22/19
16:30
Options
Preliminary option volume of 15.3M today »

Preliminary option volume…

GRTS

Gritstone Oncology

$14.57

0.86 (6.27%)

16:29
04/22/19
04/22
16:29
04/22/19
16:29
Syndicate
Gritstone Oncology files to sell 6.5M shares of common stock »

Goldman Sachs & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACC

American Campus

$46.47

-0.87 (-1.84%)

16:28
04/22/19
04/22
16:28
04/22/19
16:28
Earnings
American Campus reports Q1 FFO 69c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 01

    May

GES

Guess

$16.66

-0.41 (-2.40%)

16:26
04/22/19
04/22
16:26
04/22/19
16:26
Hot Stocks
Guess to initiate $150M stock buyback »

Guess intends to initiate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GES

Guess

$16.66

-0.41 (-2.40%)

16:26
04/22/19
04/22
16:26
04/22/19
16:26
Syndicate
Guess to offer $250M in convertible senior notes »

The company states the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.26

1.17 (107.34%)

16:26
04/22/19
04/22
16:26
04/22/19
16:26
Hot Stocks
Regional Health Properties not in compliance with NYSE listing rules »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBL

BHP Billiton plc

$48.94

0.225 (0.46%)

16:24
04/22/19
04/22
16:24
04/22/19
16:24
Downgrade
BHP Billiton plc rating change  »

BHP Billiton plc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$67.89

-0.66 (-0.96%)

16:23
04/22/19
04/22
16:23
04/22/19
16:23
Earnings
Realty Income raises FY19 AFFO view to $3.28-$3.33 from $3.25-$3.31 »

Consensus is for FY19 FFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

GES

Guess

$16.66

-0.41 (-2.40%)

16:23
04/22/19
04/22
16:23
04/22/19
16:23
Hot Stocks
Guess cuts dividend to 11.25c per share from 22.5c »

The company states that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Group

$55.14

0.19 (0.35%)

16:23
04/22/19
04/22
16:23
04/22/19
16:23
Downgrade
BHP Group rating change  »

BHP Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEP

American Electric

$82.92

-0.04 (-0.05%)

, SRE

Sempra Energy

$125.35

-2.07 (-1.62%)

16:22
04/22/19
04/22
16:22
04/22/19
16:22
Hot Stocks
American Electric: Purchase of wind assets from Sempra 'immediately accretive' »

American Electric Power…

AEP

American Electric

$82.92

-0.04 (-0.05%)

SRE

Sempra Energy

$125.35

-2.07 (-1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 30

    Apr

  • 09

    May

  • 21

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.